Abel T., Knechtle B., Perret C., Eser P., von Arx P., Knecht H. (2005): Influence of chronic supplementation of arginine aspartate in endurance athletes on performance and substrate metabolism - a randomized, double-blind, placebo-controlled study. Int. J. Sports Med., 26(5), s. 344-349.

Alba-Roth J., Müller O.A, Schopohl J., von Werder K. (1988): Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab., 67(6), s. 1186-1189.

Alderton W.K., Cooper C.E., Knowles R.G. (2001): Nitric oxide synthases: structure, function and inhibition. Biochem. J., 357, s. 593-615.

Bansal V., Ochoa J.B. (2003): Arginine availability, arginase and immune response.Curr. Opin. Clin. Nutr. Metab. Care., 6, s. 223-228.

Beis L., Mohammad Y., Easton C., Pitsiladis Y.P. (2011): Failure of glycine-arginine-α- ketoisocaproic acid to improve high-intensity exercise performance in trained cyclists. Int. J. Sport Nutr. Exerc. Metab., 21(1), s. 33-39.

Blantz R.C., Satriano J., Gabbai F., Kelly C. (2000): Biological effects of arginine metabolites. Acta Physiol. Scand., 168, s. 21-25.

Boudjemaa B. (1989): Effet de l'arginine sur des haltérophiles en préparation competitive. Médecine Sport., 63(4), s. 186.

Buchman A.L., O'Brien W., Ou C.N., Rognerud C., Alvarez M., Dennis K., Ahn C. (1999): The effect of arginine or glycine supplementation on gastrointestinal function, muscle injury, serum amino acid concentrations and performance during a marathon run. Int. J. Sports Med., 20(5), s. 315-321.

Buford B.N., Koch A.J. (2004): Glycine-arginine-alpha-ketoisocaproic acid improves performance of repeated cycling sprints. Med. Sci. Sports Exerc., 36(4), s. 583-758.

Burtscher M., Brunner F., Faulhaber M., Hotter B., Likar R. (2005): The prolonged intake of L-arginine-L-aspartate reduces blood lactate accumulation and oxygen consumption during submaximal exercise. J. Sport Sci. Med., 4, s. 314-322.

Campbell B.I., La Bounty P.M., Roberts M. (2004): The ergogenic potential of arginine. J. Int. Soc. Sports Nutr., 1(2), s. 35-38.

Campbell B., Roberts M., Kerksick C., Wilborn C., Marcello B., Taylor L., Nassar E., Leutholtz B., Bowden R., Rasmussen C., Greenwood M., Kreider R. (2006): Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. Nutrition, 22 (9), s. 872-881.

Chromiak J.A., Antonio J. (2002): Use of amino acids as growth hormone-releasing agents by athletes. Nutrition, 18(7/8), s. 657-661.

Collier S.R., Casey D.P., Kanaley J.A. (2005): Growth hormone responses to varying doses of oral arginine. Growth Horm. IGF Res., 15(2), s. 136-139.

Colombani P.C., Bitzi R., Frey-Rindova P., Frey W., Arnold M., Langhans W., Wenk C. (1999): Chronic arginine aspartate supplementation in runners reduces total plasma amino acid level at rest and during a marathon run. Eur. J. Nutr., 38(6), s. 263-270.

Deves R., Boyd C.A.R. (1998): Transporters for cationic amino acids in animal cells: discovery, structure and function. Physiol. Rev., 78, s. 487-545.

Evans R.W., Fernstrom J.D., Thompson J., Morris S.M. Jr., Kuller L.H. (2004): Biochemical responses of healthy subjects during dietary supplementation with L-arginine. J. Nutr. Biochem., 15(9), s. 534-539.

Filippin L.I., Moreira A.J., Marroni N.P., Xavier R.M. (2009): Nitric oxide and repair of skeletal muscle injury. Nitric Oxide, 21(3-4), s. 157-163.

Flynn N.E., Meininger C.J., Haynes T.E., Wu G. (2002): The metabolic basis of arginine nutrition and pharmacotherapy. Biomed. Pharmather., 56, s. 427-438.

Gremion G., Pahud P., Gobelet C. (1987): Aspartate d'arginine et activité musculaire. Schweiz Z. Sportmed., 35 (1), s. 21-24.

Hauk J.M., Hosey R.G. (2006): Nitric oxide therapy: fact or fiction? Curr. Sports Med. Rep., 5(4), s. 199-202.

http://www.ausport.gov.au/ais/nutrition/supplements/classifications

Ignarro L.J., Cirino G., Casini A., Napoli C. (1999): Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol., 34, s. 879-886.

Jagiełło W., Kruszewski M., Banach J. (2010): Effects of creatine supplementation on body mass and muscle girths in bodybuilders. Biomed. Hum. Kinet., 2, s. 47-50.

Jóźków P., Mędraś M. (2009): Hormon wzrostu i IGF-1 jako substancje dopingujące w sporcie wyczynowym. Endokrynol. Pol., 60(5), s. 389-394.

Juhn M.S., Tarnopolsky M. (1998): Oral creatine supplementation and athletic performance: A critical review. Clin. J. Sport Med., 8, s. 286-297.

Kharitonov S.A., Lubec G., Lubec B., Hjelm M., Barnes P.J. (1995): L-arginine increases exhaled nitric oxide in normal human subjects. Clin. Sci., 88(2), s. 135-139.

Lancha A.H., Recco M.B., Abdalla D.S., Curi R. (1995): Effect of aspartate, asparagine, and carnitine supplementation in the diet on metabolism of skeletal muscle during moderate exercise. Physiol. Behav., 57, s. 367-371.

Léglise M. (1970): Utilisation de I'aspartate d'arginine chez 50 jeunes sportifs (espoirs nationaux). Cinesiol., 9, s. 337.

Little J.P., Forbes S.C., Candow D.G., Cornish S.M., Chilibeck P.D. (2008): Creatine, arginine alpha-ketoglutarate, amino acids, and medium-chain triglycerides and endurance and performance. Int. J. Sport Nutr. Exerc. Metab., 18(5), s. 493-508.

Liu T.H., Wu C.L., Chiang C.W., Lo Y.W., Tseng H.F., Chang C.K. (2009): No effect of short-term arginine supplementation on nitric oxide production, metabolism and performance in intermittent exercise in athletes. J. Nutr. Biochem., 20(6), s. 462-468.

Mori M., Gotoh T. (2000): Regulation of nitric oxide production by arginine metabolic enzymes. Biochem. Biophys. Res. Commun., 275, s. 715-719.

Morris S.M. Jr. (2002): Regulation of enzymes of the urea cycle and arginine metabolism. Ann. Rev. Nutr., 22, s. 87-105.

Paddon-Jones D., Børsheim E., Wolfe R.R. (2004): Potential ergogenic effects of arginine and creatine supplementation. J. Nutr.,134 (10 Suppl), s. 2888S-2895S.

Ramirez I., DeSantiago S., Tovar A.R., Torres N. (2001): Amino acid intake during lactation and amino acids of plasma and human milk. Adv. Exp. Med. Biol., 501, s. 415-421.

Salvemini D., Ischropoulos H., Cuzzocrea S. (2003): Roles of nitric oxide and superoxide in inflammation. Methods Mol. Biol., 225, 291-303.

Santos R.S., Pacheco M.T., Martins R.A., Villaverde A.B., Giana H.E., Baptista F., Zângaro R.A. (2002): Study of the effect of oral administration of L-arginine on muscular performance in healthy volunteers: an isokinetic study. Isokinet. Exerc. Sci., 10(3), s. 153-158.

Shao A., Hathcock J.N. (2008): Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul. Toxicol. Pharmacol., 50(3), s. 376-399.

Stevens B.R., Godfrey M.D., Kaminski T.W., Braith R.W. (2000): High-intensity dynamic human muscle performance enhanced by a metabolic intervention. Med. Sci. Sports Exerc., 32(12), s. 2102-2108.

Ścibor D., Czeczot H. (2005): Arginina - metabolizm i funkcje w układzie sercowo-naczyniowym. Adv. Clin. Exp. Med., (14)5, s. 1041-1050.

Tang J.E., Lysecki P.J., Manolakos J.J., MacDonald M.J., Tarnopolsky M.A., Phillips S.M. (2011): Bolus arginine supplementation affects neither muscle blood flow nor muscle protein synthesis in young men at rest or after resistance exercise. J. Nutr., 141(2), s. 195-200.

Tangphao O., Chalon S., Moreno H. Jr., Hoffman B.B., Blaschke T.F. (1999): Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia. Clin. Sci., 96, s. 199-207.

Tapiero H., Mathe G., Couvreur P., Tew K.D. (2002): l. Arginine. Biomed. Pharmacother., 56, s. 439-445.

Tarnopolsky M.A., MacLennan D.P. (2000): Creatine monohydrate supplementation enhances highintensity exercise performance in males and females. Int. J. Sport Nutr. Exerc. Metab., 10, s. 452-463.

Tentori L., Graziani G. (2007): Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? Pharmacol. Res., 55, s. 359-369.

Tong B.C., Barbul A. (2004): Cellular and physiological effects of arginine. Mini Rev. Med. Chem., 4(8), s. 823-832.

Vierck J.L., Icenoggle D.L., Bucci L., Dodson M.V. (2003): The effects of ergogenic compounds on myogenic satellite cells. Med. Sci. Sports Exerc., 35(5), s. 769-776.

Visek W.J. (1986): Arginine needs, physiological state and usual diets. A reevaluation. J. Nutr., 116, s. 36-46.

Walberg-Rankin J., Hawkins C.E., Fild D.S., Sebolt D.R. (1994): The effect of oral arginine during energy restriction in male weight trainers. J. Strength Cond. Res., 8(3), s. 170-177.

Wideman L., Weltman J.Y., Patrie J.T., Bowers C.Y., Shah N., Story S., Veldhuis J.D., Weltman A. (2000): Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol., 279(4), s. R1467-R1477.

Wu G., Meininger C.J. (2002): Regulation of nitric oxide synthesis by dietary factors. Ann. Rev. Nutr., 22, s. 61-86.

Wu G., Meininger C.J., Knabe D.A., Bazer F.W., Rhoads J.M. (2000): Arginine nutrition in development, health and disease. Curr. Opin. Clin. Nutr. Metab. Care, 3: 59-66.

Wu G., Morris S.M. (1998): Arginine metabolism: nitric oxide and beyond. Biochem. J., 336 s. 1-17.

Wyss M., Kaddurah-Daouk R. (2000): Creatine and creatinine metabolism. Physiol. Rev., 80, s. 1107-1113.

Ziegenfuss T.N., Rogers M., Lowery L., Mullins N., Mendel R., Antonio J., Lemon P. (2002): Effect of creatine loading on anaerobic performance and skeletal muscle volume in NCAA Division I athletes. Nutrition, 18(5), s. 397-402.